TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
Yazar: | Feneberg, E |
---|---|
Diğer Yazarlar: | Turner, M |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2019
|
Konular: |
Benzer Materyaller
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
Yazar:: Rachel H. Tan, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
Yazar:: Yuhan Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
Yazar:: Piotr Włodarczyk, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
Yazar:: Joanna Iłżecka
Baskı/Yayın Bilgisi: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
Yazar:: Joanna Iłżecka
Baskı/Yayın Bilgisi: (2017-12-01)